Expression of macrophage markers in cryoglobulinemic glomerulonephritis - a possible role of CXCL9

D'Amico, 1995, Cryoglobulinemic glomerulonephritis: a membranoproliferative glomerulonephritis induced by hepatitis C virus, Am J Kidney Dis, 25, 361, 10.1016/0272-6386(95)90095-0 Johnson, 1993, Membranoproliferative glomerulonephritis associated with hepatitis C virus infection, N Engl J Med, 328, 465, 10.1056/NEJM199302183280703 McGuire, 2006, Brief communication: Glomerulonephritis in patients with hepatitis C cirrhosis undergoing liver transplantation, Ann Intern Med, 144, 735, 10.7326/0003-4819-144-10-200605160-00007 Smith, 2005, Pathogenic mechanisms in membranoproliferative glomerulonephritis, Curr Opin Nephrol Hypertens, 14, 396, 10.1097/01.mnh.0000172729.60122.f9 Trendelenburg, 2005, The role of complement in cryoglobulin-induced immune complex glomerulonephritis, J Immunol, 175, 6909, 10.4049/jimmunol.175.10.6909 Mühlfeld, 2003, Deletion of the fcgamma receptor IIb in thymic stromal lymphopoietin transgenic mice aggravates membranoproliferative glomerulonephritis, Am J Pathol, 163, 1127, 10.1016/S0002-9440(10)63472-4 Taneda, 2003, Growth factor expression in a murine model of cryoglobulinemia, Kidney Int, 63, 576, 10.1046/j.1523-1755.2003.00778.x Eddy, 2002, Plasminogen activator inhibitor-1 and the kidney, Am J Physiol Renal Physiol, 283, F209, 10.1152/ajprenal.00032.2002 Fogo, 2003, Renal fibrosis: not just PAI-1 in the sky, J Clin Invest, 112, 326, 10.1172/JCI19375 Huang, 2005, An unexpected role of plasminogen activator inhibitor-type 1 (PAI-1) in renal fibrosis, Kidney Int, 67, 2502, 10.1111/j.1523-1755.2005.00368.x Guo, 2011, Macrophages are essential contributors to kidney injury in murine cryoglobulinemic membranoproliferative glomerulonephritis, Kidney Int, 80, 946, 10.1038/ki.2011.249 Mosser, 2008, Exploring the full spectrum of macrophage activation, Nat Rev Immunol, 8, 958, 10.1038/nri2448 Taneda, 2001, Cryoglobulinemic glomerulonephritis in thymic stromal lymphopoietin transgenic mice, Am J Pathol, 159, 2355, 10.1016/S0002-9440(10)63085-4 Alpers, 1989, Monoclonal immunoglobulin deposition disease in a renal allograft: probable recurrent disease in a patient without myeloma, Am J Kidney Dis, 13, 418, 10.1016/S0272-6386(89)80026-5 Irshad, 2008, Hepatitis C virus (HCV): a review of immunological aspects, Int Rev Immunol, 27, 497, 10.1080/08830180802432178 Gonzalez, 2011, Chronic viral hepatitis: epidemiology, molecular biology, and antiviral therapy, Front Biosci, 16, 225, 10.2741/3685 Charo, 2006, The many roles of chemokines and chemokine receptors in inflammation, N Engl J Med, 354, 610, 10.1056/NEJMra052723 Heydtmann, 2009, Chemokines in the immunopathogenesis of hepatitis C infection, Hepatology, 49, 676, 10.1002/hep.22763 Kurelac, 2012, Chemokine CXCL10 at week 4 of treatment predicts sustained virological response in patients with chronic hepatitis C, J Interferon Cytokine Res, 32, 386, 10.1089/jir.2012.0006 Wuest, 2006, CD4+ T cell migration into the cornea is reduced in CXCL9 deficient but not CXCL10 deficient mice following herpes simplex virus type 1 infection, Cell Immunol, 243, 83, 10.1016/j.cellimm.2007.01.001 Salazar-Mather, 2000, A chemokine-to-cytokine-to-chemokine cascade critical in antiviral defense, J Clin Invest, 105, 985, 10.1172/JCI9232 Segerer, 2001, Expression of chemokines and chemokine receptors during human renal transplant rejection, Am J Kidney Dis, 37, 518, 10.1053/ajkd.2001.22076 Hauser, 2005, Prediction of acute renal allograft rejection by urinary monokine induced by IFN-gamma (MIG), J Am Soc Nephrol, 16, 1849, 10.1681/ASN.2004100836 Hu, 2009, Noninvasive detection of acute and chronic injuries in human renal transplant by elevation of multiple cytokines/chemokines in urine, Transplantation, 87, 1814, 10.1097/TP.0b013e3181a66b3e Matz, 2006, Early post-transplant urinary IP-10 expression after kidney transplantation is predictive of short- and long-term graft function, Kidney Int, 69, 1683, 10.1038/sj.ki.5000343 Jackson, 2011, Urinary chemokines CXCL9 and CXCL10 are noninvasive markers of renal allograft rejection and BK viral infection, Am J Transplant, 11, 2228, 10.1111/j.1600-6143.2011.03680.x Paust, 2012, Chemokines play a critical role in the cross-regulation of Th1 and Th17 immune responses in murine crescentic glomerulonephritis, Kidney Int, 82, 72, 10.1038/ki.2012.101 Menke, 2008, CXCL9, but not CXCL10, promotes CXCR3-dependent immune-mediated kidney disease, J Am Soc Nephrol, 19, 1177, 10.1681/ASN.2007111179